GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400

N/A

Manufactured by CVS Pharmacy

28 FDA adverse event reports analyzed

Last updated: 2026-04-15

About GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400

GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by CVS Pharmacy. The most commonly reported adverse reactions for GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 include EYE IRRITATION, OCULAR DISCOMFORT, VISION BLURRED, ASTHENOPIA, CATARACT. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400.

Top Adverse Reactions

EYE IRRITATION2 reports
OCULAR DISCOMFORT2 reports
VISION BLURRED2 reports
ASTHENOPIA1 reports
CATARACT1 reports
CONDITION AGGRAVATED1 reports
CONFUSIONAL STATE1 reports
DRUG INEFFECTIVE1 reports
ERYTHEMA OF EYELID1 reports
EYE DISCHARGE1 reports
EYE MOVEMENT DISORDER1 reports
EYE PAIN1 reports
EYE SWELLING1 reports
FEAR1 reports
FOREIGN BODY SENSATION IN EYES1 reports
HOSPITALISATION1 reports
INSOMNIA1 reports
INSTILLATION SITE DISCOMFORT1 reports
INSTILLATION SITE IRRITATION1 reports
KERATITIS1 reports
OCULAR HYPERAEMIA1 reports
PRODUCT APPEARANCE CONFUSION1 reports
PRODUCT QUALITY ISSUE1 reports
SCLERAL DISCOLOURATION1 reports
SENSATION OF FOREIGN BODY1 reports

Report Outcomes

Out of 11 classified reports for GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400:

Serious 63.6%Non-Serious 36.4%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female6 (60.0%)
Male4 (40.0%)

Reports by Age

Age 341 reports
Age 391 reports
Age 491 reports
Age 561 reports
Age 611 reports
Age 631 reports
Age 651 reports
Age 871 reports
Age 901 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400?

This profile reflects 28 FDA FAERS reports that mention GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400?

Frequently reported terms in FAERS include EYE IRRITATION, OCULAR DISCOMFORT, VISION BLURRED, ASTHENOPIA, CATARACT, CONDITION AGGRAVATED. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400?

Labeling and FAERS entries often list CVS Pharmacy in connection with GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.